Medicus Pharma Ltd.
MDCX Nasdaq
SEC CIK 1997296
Follow Medicus Pharma Ltd.
Weekly email: filings, results
Net income
−$15.2M
+27.5% vs same quarter last year
EPS, diluted
−$11.64
Operating cash flow
−$15.9M
−135.9% vs same quarter last year
Operating income
−$14.5M
+6.3% vs same quarter last year
Source: SEC XBRL filings · latest filing
Show the numbers
| Year | Net income |
|---|---|
| FY25 | −$47.3M |
| FY24 | −$11.2M |
| FY23 | −$5.3M |
| FY22 | - |